共 293 条
[1]
High KP(2012)HIV and aging: state of knowledge and areas of critical need for research. A report to the NIH Office of AIDS Research by the HIV and Aging Working Group J Acquir Immune Defic Syndr 60 S1-S18
[2]
Brennan-Ing M(2010)Does antiretroviral therapy increase or decrease the risk of cardiovascular disease? Curr HIV/AIDS Rep 7 92-98
[3]
Clifford DB(2007)Increased acute myocardial infarction rates and cardiovascular risk factors among patients with human immunodeficiency virus disease J Clin Endocrinol Metab 92 2506-2512
[4]
Cohen MH(2012)Sudden cardiac death in patients with human immunodeficiency virus infection J Am Coll Cardiol 59 1891-1896
[5]
Currier J(2011)Cardiovascular implications from untreated human immunodeficiency virus infection European Heart J 32 945-951
[6]
Deeks SG(2005)Race/ethnicity, income, major risk factors, and cardiovascular disease mortality Am J Public Health 95 1417-1423
[7]
Deren S(2009)Reduction in circulating markers of endothelial dysfunction in HIV-infected patients during antiretroviral therapy HIV Med 10 79-87
[8]
Effros RB(2011)Early changes in inflammatory and pro-thrombotic biomarkers in patients initiating antiretroviral therapy with abacavir or tenofovir BMC Infect Dis 11 40-468
[9]
Gebo K(2011)Change in high-sensitivity C-reactive protein levels following initiation of efavirenz-based antiretroviral regimens in HIV-infected individuals AIDS Res Hum Retroviruses 27 461-1556
[10]
Gorozy JJ(2009)Randomized, double-blind, placebo-matched, multicenter trial of abacavir/lamivudine or tenofovir/emtricitabine with lopinavir/ritonavir for initial HIV treatment AIDS 23 1547-1665